Researchers at the University of Queensland (UG) have published a new paper exploring 3D printing’s role in the future of personalized medicine for patients. According to pharmacist, UQ PhD student and lead author of the study Liam Krueger, the technology is refined enough to accurately print specialized dosages onsite in hospitals and pharmacies in coming years. Through the study, the researchers are hoping to accelerate the advancement of 3D printed pharmaceuticals within Australia and beyond. “3D printing is regularly used in other medical settings such as dentistry to create implants, however the utilization of the technology is lagging in the pharmaceutical space,” said Krueger. “With this research we are hoping to gain more momentum for the implementation of this technology which would be an incredible opportunity for the future of the Australian pharmaceutical landscape.” Spritam, the world’s first FDA-approved 3D printed drug. Photo via Aprecia 3D printing’s pharmaceutical progess While… read more